Arvinas Ownership | Who Owns Arvinas?
Arvinas Ownership Summary
Arvinas is owned by 95.88% institutional investors, 6.85% insiders. Vanguard group is the largest institutional shareholder, holding 11.76% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.
ARVN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arvinas | 95.88% | 6.85% | -2.73% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 8.56M | 11.76% | $72.94M |
| Blackrock funding, inc. /de | 6.80M | 9.34% | $57.96M |
| Blackrock | 6.26M | 8.70% | $166.61M |
| Price t rowe associates inc /md/ | 4.10M | 5.69% | $78.66M |
| Pfizer | 3.46M | 4.75% | $25.45M |
| Logos global management lp | 3.30M | 4.53% | $24.29M |
| Ubs group | 2.04M | 2.83% | $39.08M |
| Geode capital management | 1.67M | 2.29% | $14.23M |
| State street | 1.64M | 2.28% | $31.38M |
| Opaleye management | 1.63M | 2.25% | $33.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| New leaf venture partners | 1.59M | 22.04% | $11.67M |
| Aquilo capital management | 328.77K | 9.50% | $6.30M |
| Opaleye management | 1.63M | 5.89% | $33.64M |
| Pfizer | 3.46M | 4.42% | $25.45M |
| Nextech invest | 1.41M | 4.38% | $27.00M |
| Logos global management lp | 3.30M | 2.69% | $24.29M |
| Arbiter partners capital management | 452.79K | 2.30% | $3.86M |
| 22nw, lp | 413.53K | 1.92% | $3.04M |
| Ikarian capital | 850.00K | 1.20% | $6.26M |
| Boxer capital | 608.61K | 0.85% | $16.20M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Logos global management lp | 3.30M | 2.69% | 3.30M |
| Ubs group | 2.04M | 0.01% | 1.57M |
| Caption management | 1.34M | 0.11% | 1.28M |
| Acadian asset management | 1.43M | 0.02% | 1.27M |
| Norges bank | 1.24M | 0.00% | 1.24M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | - | - | -6.73M |
| Rtw investments, lp | - | - | -3.33M |
| Bellevue group | - | - | -2.39M |
| Paradigm biocapital advisors lp | - | - | -2.34M |
| Alyeska investment group | - | - | -1.80M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.24M | 0.00% | 1.24M | $23.84M |
| Armistice capital | 560.00K | 0.07% | 560.00K | $4.12M |
| Arbiter partners capital management | 452.79K | 2.30% | 452.79K | $3.86M |
| 22nw, lp | 413.53K | 1.92% | 413.53K | $3.04M |
| First trust advisors lp | 98.26K | 0.00% | 98.26K | $837.20K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -6.00 |
| Smartleaf asset management | -8.00 |
| Capital advisors | -28.00 |
| Avion wealth | -33.00 |
| Bessemer group | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 229 | 1.33% | 69,799,900 | 12.46% | 95 | 1.31% | 130 | 2.36% | 52 | -10.34% |
| Mar 31, 2025 | 227 | 7.08% | 64,055,484 | -16.35% | 88 | 0.78% | 127 | 13.39% | 58 | 13.73% |
| Dec 31, 2024 | 208 | -4.59% | 76,287,067 | 7.32% | 105 | 1.09% | 111 | 9.90% | 51 | -22.73% |
| Sep 30, 2024 | 217 | 3.33% | 71,015,986 | 0.13% | 98 | 1.01% | 99 | -18.18% | 67 | 26.42% |
| Jun 30, 2024 | 210 | -7.89% | 70,926,259 | 4.97% | 98 | 1.11% | 121 | - | 53 | -18.46% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 2.38M | 3.46% | - |
| Vanguard US Total Market Shares ETF | 1.93M | 2.81% | 2.43K |
| Vanguard Total Stock Mkt Idx Inv | 2.01M | 2.75% | -44.64K |
| iShares Russell 2000 ETF | 1.60M | 2.18% | - |
| Vanguard Explorer Inv | 1.56M | 2.13% | 683.33K |
| Vanguard Strategic Equity Inv | 1.25M | 1.71% | 594.88K |
| Vanguard Small Cap Index | 841.18K | 1.15% | -5.64K |
| JPMorgan Small Cap Growth A | 755.08K | 1.10% | -8.49K |
| T. Rowe Price Small-Cap Stock | 702.69K | 1.02% | 94.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 747.55K | 1.02% | -326.16K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 07, 2025 | Loomis David K | Chief Accounting Officer | Sell | $2.27K |
| Sep 22, 2025 | Morrison Briggs | - | Buy | $227.01K |
| Jun 24, 2025 | Saik Andrew | Chief Financial Officer | Sell | $43.38K |
| Jun 17, 2025 | Cacace Angela M | Chief Scientific Officer | Sell | $19.35K |
| Mar 18, 2025 | Berkowitz Noah | Chief Medical Officer | Sell | $74.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 1 |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | 1 |
ARVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools